We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

9 hedge funds and large institutions have $670K invested in China Pharma Holdings in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

29% more funds holding

Funds holding: 7 → 9 (+2)

3% more capital invested

Capital invested by funds: $650K → $670K (+$20K)

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$9.13K
2
Citadel Advisors
Citadel Advisors
Florida
+$7.74K
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$6.09K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.92K
5
UBS Group
UBS Group
Switzerland
+$1.14K

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$7K

CPHI Hedge Fund Activity: Q1 2017 in Review

9 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q1 2017, worth a combined $670K — up 3.1% from $650K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CPHI positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $9.13K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $7K sold.

  • 9 institutional investors held China Pharma Holdings (CPHI) as of Q1 2017, up from 7 in Q4 2016.
  • Funds reported $670K of China Pharma Holdings stock for Q1 2017, up 3.1% quarter-over-quarter.
  • 3 funds opened new China Pharma Holdings positions in Q1 2017 and 1 closed out, a net change of +2 holders.
  • The largest China Pharma Holdings buyer in Q1 2017 was Renaissance Technologies, an estimated $9.13K added.
  • The largest China Pharma Holdings seller in Q1 2017 was Virtu KCG Holdings, an estimated $7K sold.

Based on aggregated 13F filings for Q1 2017.